Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Capital Corp Essex currently holds 393,704 shares of Neos Therapeutics, Inc. (NEOS), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Capital Corp Essex has been a net buyer of NEOS stock. They have purchased $450.0K and sold $0 worth of shares.
Capital Corp Essex's most recent insider trade was on Jul 28, 2015, when they sold 386,415 shares at $0.00 per share.
Capital Corp Essex serves as Executive at Neos Therapeutics, Inc. (NEOS). They have executed 12 insider transactions totaling $450.0K over their tenure at the company.
Capital Corp Essex holds the position of Executive at Neos Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 11 years and currently hold a stake valued at $0.
Capital Corp Essex has shown a buying trading pattern, with $450.0K in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by Capital Corp Essex was on Jul 28, 2015, when they purchased $450.0K worth of NEOS shares. This transaction involved 30,000 shares at $15.00 per share.
Capital Corp Essex currently owns 393,704 shares of Neos Therapeutics, Inc. (NEOS), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Capital Corp Essex's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Capital Corp Essex has 12 Form 4 filings on record as an insider at Neos Therapeutics, Inc..
Set alerts for Capital Corp Essex and 40,000+ other insiders.